Compellingly, a moderate up‐regulation of OTUB1 decreases the overall survival of lung adenocarcinoma patients with wt KRAS, suggesting that only medium levels of OTUB1 confers advantage to cancer cells and/or could affect their chemotherapeutic resistance. This evidence concerns the gene KRAS and lung adenocarcinoma.